Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK

Food Additives and Contaminants - Part A

Volumn 29, Issue 2, 2012, Pages 269-276

  Hepworth, S J ^a   Hardie, L J ^a   Fraser, L K ^a   Burley, V J ^a   Mijal, R S ^b   Wild, C P ^c   Azad, R ^d   Mckinney, P A ^a   Turner, P C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cereals; Exposure assessment; LC MS; Mycotoxins; Trichothecenes

Indexed keywords

BIOMARKERS; OBSTETRICS; SURVEYS;

CEREALS; EXPOSURE ASSESSMENT; LC/MS; MYCOTOXINS; TRICHOTHECENES;

BAKERIES;

CREATININE; VOMITOXIN;

ADOLESCENT; ADULT; ARTICLE; ASIAN; BREAD; CESAREAN SECTION; CREATININE URINE LEVEL; DIETARY INTAKE; FEMALE; FOOD CONTAMINATION; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; NUTRITIONAL ASSESSMENT; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH ASIA; THIRD TRIMESTER PREGNANCY; UNITED KINGDOM; URINALYSIS;

EID: 84857416407     PISSN: 19440049     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/19440049.2010.551301     Document Type: Article

References (39)

1. Amuzie CJ, Pestka JJ. 2010. Suppression of insulin-like growth factor acid-labile subunit expression - a novel mechanism for deoxynivalenol-induced growth retardation. Toxicol Sci. 113:412-421.
2. Bouhet S, Oswald IP. 2005. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet Immunol Immunopathol. 108:199-209.
3. Bradford District Infant Mortality Commission. 2006. Final report; [cited 2009 Dec 8]. Available from: http://www.bradford.nhs.uk/ebm/BDIMC/Pages/TheReport.aspx/
4. Choi HJ, Yang H, Park SH, Moon Y. 2009. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol. Toxicol Appl Pharmacol. 240:46-54.
5. Cirillo T, Ritieni A, Galvano F, Cocchieri RA. 2003. Natural co-occurrence of deoxynivalenol and fumonisins B-1 and B-2 in Italian marketed foodstuffs. Food Addit Contam. 20:566-571.
6. Collins TF, Sprando RL, Black TN, Olejnik N, Eppley RM, Hines FA, Rorie J, Ruggles DI. 2006. Effects of deoxynivalenol (DON, vomitoxin) on in utero development in rats. Food Chem Toxicol. 44:747-757.
7. Council for Agricultural Science and Technology (CAST). 2003. Mycotoxins: risks in plant, animal, and human systems. Task Force Report No. 139. Ames, Iowa, US: CAST.
8. Cummins C, Winter H, Cheng KK, Maric R, Silcocks P, Varghese C. 1999. An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. J Public Health Med. 21:401-406.
9. Gallery EDM, Ross M, Gyory AZ. 1996. 24-Hour urinary creatinine excretion is not altered in human pregnancy. Hypertension Preg. 15(2):257-261.
10. Garon D, Richard E, Sage L, Bouchart V, Pottier D, Lebailly P. 2006. Mycoflora and multi-mycotoxin detection in corn silage: experimental study. J Agric Food Chem. 54:3479-3484.
11. Goyarts T, Danicke S, Brussow KP, Valenta H, Ueberschar KH, Tiemann U. 2007. On the transfer of the Fusarium toxins deoxynivalenol (DON) and zearalenone (ZON) from sows to their fetuses during days 35-70 of gestation. Toxicol Lett. 171:38-49.
12. International Agency for Research on Cancer (IARC). 2002. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon (France): IARC.
13. Jackson LS, Bullerman LB. 1999. Effect of processing on Fusarium mycotoxins. Adv Exp Med Biol. 459:243-261.
14. Jakovac-Strajn B, Vengust A, Pestevsek U. 2009. Effects of a deoxynivalenol contaminated diet on the reproductive performance and immunoglobulin concentrations in pigs. Vet Rec. 165:713-718.
15. Kristensen P, Irgens LM, Andersen A, Bye AS, Sundheim L. 1997. Gestational age, birth weight, and perinatal death among births to Norwegian farmers, 1967-1991. Am J Epidemiol. 146:329-338.
16. Leblanc JC, Tard A, Volatier JLLL, Vergerk P. 2005. Estimated dietary exposure to principal food mycotoxins from the first French Total Diet Study. Food Addit Contam. 22:652-672.
17. Macfarlane GJ, Lunt M, Palmer B, Afzal C, Silman AJ, Esmail A. 2007. Determining aspects of ethnicity amongst persons of South Asian origin: the use of a surname-classification programme (Nam Pehchan). Public Health. 121:231-236.
18. Merlo DF, Wild CP, Kogevinas M, Kyrtopoulos S, Kleinjans J. 2009. NewGeneris: a European study on maternal diet during pregnancy and child health. Cancer Epidemiol Biomarkers Prev. 18:5-10.
19. Miller JD. 1995. Fungi and mycotoxins in grain - implications for stored-product research. J Stored Prod Res. 31:1-16.
20. Myllynen P, Immonen E, Kummu M, Vakakangas K. 2009. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol. 5:1483-1499.
21. Patel S, Hazel CM, Winterton AGM, Mortby E. 1996. Survey of ethnic foods for mycotoxins. Food Addit Contam. 13:833-841.
22. Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev. 8:39-69.
23. Pinton P, Nougayrede JP, Del Rio JC, Moreno C, Marin DE, Ferrier L, Bracarense A, Kolf-Clauw M, Oswald IP. 2009. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol. 237:41-48.
24. Prelusky DB, Rotter BA, Thompson BK, Trenholm HL. 1997. Effect of the appetite stimulant cyproheptadine on deoxynivalenol-induced reductions in feed consumption and weight gain in the mouse. J Environ Sci Health B. 32:429-448.
25. Raynor P. 2008. Born in Bradford, a cohort study of babies born in Bradford, and their parents: protocol for the recruitment phase. BMC Public Health. 8:327-339.
26. Rotter BA, Prelusky DB, Pestka JJ. 1996. Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Health B Crit Rev. 48:1-34.
27. Scientific Committee on Food (SCF). 2002. Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol. SCF/CS/CNTM/MYC/27 Final; [cited 2007 Jun 15]. Available from: http://europa.eu.int/comm/food/fs/sc/scf/out123_en.pdf/
28. SCOOP (Scientific Cooperation). 2003. Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. SCOOP Task 3.2.10 Final report; [cited 2007 Jun 15]. Available from: http://europa.eu.int/comm/food/fs/scoop/task3210.pdf/
29. Sundstøl Eriksen G, Pettersson H. 2003. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit Contam. 20:579-582.
30. Tiemann U, Brussow KP, Danicke S, Vanselow J. 2008. Feeding of pregnant sows with mycotoxin-contaminated diets and their non-effect on foetal and maternal hepatic transcription of genes of the insulin-like growth factor system. Food Addit Contam A. 25:1365-1373.
31. Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. 2008. Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. J Expo Sci Environ Epidemiol. 18:392-399.
32. Turner PC, Hopton RP, Lecluse Y, White KL, Fisher J, Lebailly P. 2010. Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J Agri Food Chem. 58:5206-5212.
33. Turner PC, Rothwell JA, White KLM, Gong Y, Cade JE, Wild CP. 2008. Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom. Environ Health Perspect. 116:21-25.
34. Turner PC, Taylor EF, White KLM, Cade JE, Wild CP. 2009. A comparison of 24 h urinary deoxynivalenol with recent v. average cereal consumption for UK adults. Br J Nutr. 102:1276-1284.
35. Turner PC, White KLM, Burley BJ, Hopton PH, Rajendram A, Fisher J, Cade JE, Wild CP. 2010. A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults. Biomarkers. 15(6):553-562.
36. UK Food Standards Agency (FSA). 2003. Survey of retail cereal products for tricothecenes and zearalenone 35/03. London, UK: FSA.
37. Varley H. 1967. Practical clinical biochemistry. London, UK: William Weimann Medical Books & Interscience Books.
38. Voss KA. 2010. A new perspective on deoxynivalenol and growth suppression. Toxicol Sci. 113:281-283.
39. Yoshizawa T, Cote LM, Swanson SP, Buck WB. 1986. Confirmation of DOM-1, a de-epoxidation metabolite of deoxynivalenol in biological fluids of lactating cows. Agric Biol Chem. 50:227-229.